These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30321129)

  • 41. Analysis of mushroom exposures in Texas requiring hospitalization, 2005-2006.
    Barbee G; Berry-Cabán C; Barry J; Borys D; Ward J; Salyer S
    J Med Toxicol; 2009 Jun; 5(2):59-62. PubMed ID: 19415588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Impact of personality disorders in a sample of 212 homeless drug users].
    Combaluzier S; Gouvernet B; Bernoussi A
    Encephale; 2009 Oct; 35(5):448-53. PubMed ID: 19853718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylphenidate abuse in Texas, 1998-2004.
    Forrester MB
    J Toxicol Environ Health A; 2006 Jun; 69(12):1145-53. PubMed ID: 16728377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
    Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database.
    Lai MW; Klein-Schwartz W; Rodgers GC; Abrams JY; Haber DA; Bronstein AC; Wruk KM
    Clin Toxicol (Phila); 2006; 44(6-7):803-932. PubMed ID: 17015284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prevalence and characteristics of homelessness in the NSW substance treatment population: implications for practice.
    Allan J; Kemp M
    Soc Work Health Care; 2014; 53(2):183-98. PubMed ID: 24483335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bath salts and other emerging toxins.
    Thornton MD; Baum CR
    Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of synthetic cannabinoid use in Australia.
    Barratt MJ; Cakic V; Lenton S
    Drug Alcohol Rev; 2013 Mar; 32(2):141-6. PubMed ID: 23043552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Texas Bull Nettle (Cnidoscolus texanus) Exposures Reported to Texas Poison Centers.
    Forrester MB
    Wilderness Environ Med; 2017 Jun; 28(2):79-83. PubMed ID: 28385365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 and contamination: impact on exposures to alcohol-based hand sanitizers reported to Texas Poison Control Centers, 2020.
    Phillips T; Schulte JM; Smith EA; Roth B; Kleinschmidt KC
    Clin Toxicol (Phila); 2021 Oct; 59(10):926-931. PubMed ID: 33605823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Work-related health emergency cases due to hydrofluoric acid exposures reported to Texas poison centers.
    Forrester MB
    Int J Occup Med Environ Health; 2012 Sep; 25(4):456-62. PubMed ID: 23086633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Notes from the field: Severe illness associated with synthetic cannabinoid use - Brunswick, Georgia, 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(46):939. PubMed ID: 24257204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of synthetic cannabinoids in patients with psychotic disorders: case series.
    Celofiga A; Koprivsek J; Klavz J
    J Dual Diagn; 2014; 10(3):168-73. PubMed ID: 25392292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between sociodemographic factors and exposures and utilization of poison centers in Texas, 1998-2002.
    Forrester MB
    J Toxicol Environ Health A; 2005 May; 68(10):755-61. PubMed ID: 16020174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthetic cannabinoid use in New Zealand: a brief evaluation of inquiries to the New Zealand National Poisons Centre.
    Schep LJ; Slaughter RJ; Temple WA
    N Z Med J; 2011 Dec; 124(1347):99-101. PubMed ID: 22237580
    [No Abstract]   [Full Text] [Related]  

  • 56. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Future of Substance Abuse Now: Relationships among Adolescent Use of Vaping Devices, Marijuana, and Synthetic Cannabinoids.
    Tai H; Swartz MD; Marsden D; Perry CL
    Subst Use Misuse; 2021; 56(2):192-204. PubMed ID: 33412950
    [No Abstract]   [Full Text] [Related]  

  • 58. Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014.
    Palamar JJ; Su MK; Hoffman RS
    Am J Drug Alcohol Abuse; 2016; 42(1):39-47. PubMed ID: 26678258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adolescent synthetic cathinone exposures reported to Texas poison centers.
    Forrester MB
    Pediatr Emerg Care; 2013 Feb; 29(2):151-5. PubMed ID: 23364377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.